SEC Form 4 · accession 0001562180-18-001012
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Lloyd Miller
Officer — Sr. VP, GC & Corp. Sec.
Period of report
Feb 13, 2018
Accepted (ET)
Feb 15, 2018 · 6:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 13, 2018 | A | 2,785 | $93.00 | A | 7,403 | I | Non-Qualified Deferred Compensation Plan |
| Common StockF2 | Feb 13, 2018 | A | 2,828 | $93.00 | A | 10,231 | I | Non-Qualified Deferred Compensation Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Bonus & Incentive share grant
- F22015 PSU (PP14) award vesting